focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMast Energy. Regulatory News (MAST)

Share Price Information for Mast Energy. (MAST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.215
Bid: 0.20
Ask: 0.23
Change: 0.00 (0.00%)
Spread: 0.03 (15.00%)
Open: 0.215
High: 0.215
Low: 0.215
Prev. Close: 0.215
MAST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MED Binding JVA Completion Update

22 Sep 2023 07:00

RNS Number : 2868N
Mast Energy Developments PLC
22 September 2023
 

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

 

Dated: 22 September 2023

 

Mast Energy Developments PLC ('MED' or 'the Company')

 

MED Binding Joint Venture Agreement Completion Update

 

Mast Energy Developments PLC, the UK-based multi-asset owner, developer and operator in the rapidly growing flexible power market, announces that further to its previous announcements dated 12 July 2023, 4 August 2023, and 1 September 2023 respectively, it has further extended the completion long-stop date for the first definitive and binding Joint Venture Agreement ('JVA'). Completion is now expected around mid-October 2023. The further extension is required to allow the JV investor consortium to complete the compulsory statutory process, as set out in the announcement of 1 September 2023. This process and timelines associated therewith remains beyond the control of the Company and the JV investor who remains fully committed to see this completed at the earliest possible date.

 

Although MED is continuing to work with the investor consortium, and the board have full confidence that the transaction will be completed, unless or until the first definitive and binding Joint Venture Agreement ('JVA') has been completed, Seira Capital Ltd ('Seira') remains contractually bound under the JVA, and remains in breach of its obligations thereto. Should the investor consortium fail to complete the transaction around the latest completion extension date, MED will consider all its options, including but not limited to commencing legal proceedings against Seira and affected parties, as well as alternative investment opportunities.

 

Pieter Krügel, CEO of MED, commented: "We remain confident that the investor consortium will be able to complete the transaction and the board have also received written reassurance from the investor consortium in this regard."

 

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please visit www.med.energy or contact:

 

Pieter Krügel

Info@med.energy

Mast Energy

Developments PLC

CEO

Jon Belliss

+44 (0)20 7399 9425

Novum Securities

Corporate Broker

Zainab Slemang van Rijmenant

zainab@lifacommunications.com

Lifa Communications

Investor & Media Relations Advisor

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEMFAFEDSEDU
Date   Source Headline
14th Dec 20224:35 pmRNSPrice Monitoring Extension
8th Dec 20227:00 amRNSBordesley Update
17th Nov 20227:00 amRNSCorporate Presentation
3rd Nov 20227:00 amRNSFurther Funding Secured
31st Oct 20221:41 pmRNSClarification of Pyebridge Trading Update
27th Oct 20224:41 pmRNSSecond Price Monitoring Extn
27th Oct 20224:35 pmRNSPrice Monitoring Extension
27th Oct 20222:05 pmRNSSecond Price Monitoring Extn
27th Oct 20222:00 pmRNSPrice Monitoring Extension
24th Oct 20224:35 pmRNSPrice Monitoring Extension
24th Oct 20222:05 pmRNSSecond Price Monitoring Extn
24th Oct 20222:00 pmRNSPrice Monitoring Extension
24th Oct 202211:05 amRNSSecond Price Monitoring Extn
24th Oct 202211:00 amRNSPrice Monitoring Extension
24th Oct 20229:05 amRNSSecond Price Monitoring Extn
24th Oct 20229:00 amRNSPrice Monitoring Extension
21st Oct 20224:40 pmRNSSecond Price Monitoring Extn
21st Oct 20224:35 pmRNSPrice Monitoring Extension
21st Oct 20222:06 pmRNSSecond Price Monitoring Extn
21st Oct 20222:00 pmRNSPrice Monitoring Extension
21st Oct 202211:05 amRNSSecond Price Monitoring Extn
21st Oct 202211:00 amRNSPrice Monitoring Extension
20th Oct 20224:41 pmRNSSecond Price Monitoring Extn
20th Oct 20224:35 pmRNSPrice Monitoring Extension
19th Oct 20227:00 amRNSPyebridge Trading Update
5th Oct 20227:00 amRNSMED Acquires two Projects and Secures Funding
13th Sep 20222:05 pmRNSSecond Price Monitoring Extn
13th Sep 20222:00 pmRNSPrice Monitoring Extension
23rd Aug 20227:00 amRNSHalf-year Report
8th Aug 20229:46 amRNSTR-1: Notification of major holdings
29th Jul 20222:15 pmRNSPartial Settlement Shareholder Loan & Share Issue
13th Jul 202212:46 pmRNSAppointment of Director
5th Jul 20227:00 amRNSPyebridge Trading and Operational Update
20th May 20227:00 amRNSAppointment of Chief Executive Officer
16th May 202211:24 amRNSResults of Annual General Meeting
20th Apr 20227:00 amRNSNotice of AGM
7th Apr 20227:00 amRNSGeneral Update
31st Mar 20227:00 amRNSResults for the 15 month period ended 31 Dec 2021
24th Feb 20227:00 amRNSBordesley T-4 Capacity Market Auction Results
23rd Feb 20222:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20229:00 amRNSPrice Monitoring Extension
2nd Dec 20212:36 pmRNSMED Share Issue
15th Nov 20217:00 amRNSPyebridge Steady State Operation and Production
20th Oct 20217:00 amRNSTerm Sheet for Project Development Funding Signed
7th Oct 20217:00 amRNSMED Completes Acquisition of Rochdale Power Ltd
1st Oct 20217:00 amRNSNew Board Appointment
2nd Sep 20217:00 amRNSUnaudited results for the 9 months ended June 2021
16th Aug 20217:00 amRNSMED Acquires Third Standby Generation Facility
12th Aug 202112:48 pmRNSPyebridge Correction of Address Particulars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.